Search Results for “” – Page 50 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Outcomes

1156 Publications found

Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

b

Gut

April 1, 2020

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model
Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements.

b

JAMA

March 24, 2020

p Newborn Screening

c Change patient management Highlighted Observational
Heparin sensitivity and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass.

b

European journal of anaesthesiology

March 1, 2020

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.

b

Cancer medicine

March 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Pre-procedural elevated cardiac troponin predict risk of long-term all-cause mortality after transcatheter aortic valve replacement: a meta-analysis of prospective studies.

b

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

March 1, 2020

p Cardiovascular Disease

c Clinical outcomes Meta-analysis
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.

b

Health technology assessment (Winchester, England)

March 1, 2020

p Antibiotic Guidance

c Change patient management Clinical outcomes Highlighted Operational efficiencies Patient-centeredness RCT
Clinical outcomes for chest pain patients discharged home from emergency departments using high-sensitivity versus conventional cardiac troponin assays.

b

American heart journal

March 1, 2020

p Cardiovascular Disease

c Clinical outcomes Observational
Clinical value and cost saving of therapeutic drug monitoring of infliximab in adult patients with inflammatory bowel disease.

b

Clinical medicine (London, England)

March 1, 2020

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics Observational
Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.

b

Genetics in medicine : official journal of the American College of Medical Genetics

March 1, 2020

p Pharmacogenetic and Pharmacogenomics

c Economics Review
Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies.

b

Journal of diabetes science and technology

March 1, 2020

p Diabetes

c Clinical outcomes Meta-analysis